Polivy
Payments companies reported to CMS as associated with Polivy. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Polivy, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Polivy
These are the largest totals companies reported as associated with Polivy. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Haifaa Abdulhaq | Fresno, CA | Hematology & Oncology | $65,425.48 |
| Mark Fesler | Saint Louis, MO | Hematology & Oncology | $43,849.09 |
| Stacy Lewis | Portland, OR | Medical Oncology | $41,424.22 |
| Vincent Herrin | Jackson, MS | Hematology (Internal Medicine) | $34,949.49 |
| Christopher Flowers | Houston, TX | Hematology & Oncology | $33,079.32 |
| Adolfo Diaz | San Antonio, TX | Hematology & Oncology | $29,944.94 |
| Tara Graff | Clive, IA | Medical Oncology | $28,844.28 |
| Matthew Lunning | Omaha, NE | Medical Oncology | $26,413.13 |
| Amy Sidorski | Aurora, CO | Nurse Practitioner | $25,114.82 |
| John Burke | Aurora, CO | Hematology & Oncology | $23,180.40 |
Prescribed Polivy?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.